BDB554875

CD45 Mouse anti-Rat, Unlabeled, Clone: OX-1, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB554875-Each-of-1 In Stock ₹ 25,454.00

BDB554875 - Each of 1

₹ 25,454.00

In Stock

Quantity

1

Base Price: ₹ 25,454.00

GST (18%): ₹ 4,581.72

Total Price: ₹ 30,035.72

Antigen

CD45

Classification

Monoclonal

Concentration

0.5mg/mL

Description

Ptprc; Lca; Leucocyte common antigen; RT7; T200

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C

Applications

Flow Cytometry

Clone

OX-1

Conjugate

Unconjugated

Formulation

Aqueous buffered solution containing ≤0.09% sodium azide.

Immunogen

Leukocyte Common Antigen-enriched Glycoprotein Fraction from Wistar Rat Thymocytes

Quantity

0.5 mg

Research Discipline

Immunology

Target Species

Rat

Isotype

IgG1 κ

Related Products

Img

BD Biosciences

BDB554882

--

Img

BD Biosciences

BDB553076

--

Img

BD Biosciences

BDB555480

--

Img

BD Biosciences

BDB554926

--

Img

BD Biosciences

BDB554841

--

Img

BD Biosciences

BDB553771

--

Img

BD Biosciences

BDB552128

--

Img

BD Biosciences

BDB551449

--

Description

  • The OX-1 antibody reacts with all molecular forms of CD45 (Leukocyte Common Antigen) on all hematopoietic cells except erythrocytes
  • CD45 is a member of the Protein Tyrosine Phosphatase (PTP) family: Its intracellular (COOH-terminal) region contains two PTP catalytic domains, and the extracellular region is highly variable due to alternative splicing of exons 4, 5, and 6 (designated A, B, and C, respectively), plus differing levels of glycosylation
  • The CD45 isoforms detected in the rat are cell type-, maturation-, and activation state-specific
  • The CD45 isoforms play complex roles in T-cell and B-cell antigen receptor signal transduction
  • This antibody is routinely tested by flow cytometric analysis
  • Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.